F4513-40
CAS Number
162359-56-0Grade
Highly PurifiedMolecular Formula
C19H33NO2•HClMolecular Weight
343.93EU Commodity Code
38220090Shipping Temp
Blue IceStorage Temp
-20°CFingolimod Hydrochloride (FTY-720A, FTY720, D04187, 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol Hydrochloride)
Fingolimod (FTY720), a sphingosine 1-phosphate (S1P) analog, is a novel immunosuppressant drug that induces lymphopenia by preventing emergence of lymphocytes from lymph nodes. Fingolimod is a sphingosine-1-phosphate receptor 1 modulator and is in phase III clinical trials for relapsing-remitting multiple sclerosis.
Solubility
Soluble in DMSO at 100mg/ml; soluble in ethanol at 100mg/ml; very poorly soluble in water. Up to 25ul of a solution of 13.8mg/ml (40mM) F4513-40 in 100% DMSO can be diluted into 5ml of plain water without precipitation, giving a final concentration of 200uM. In contrast, even a 1:1000 dilution of the same 13.8mg/ml DMSO stock solution into 10mM PBS, pH 7 results in a precipitate. Thus, F4513-40 solubility in PBS is likely to be well below 100uM, perhaps as low as 1-10ug/ml. Either DMSO, ethanol or plain water should be used as the solvent until the final dilution is made into culture medium
Calculated
C=66.35% H=9.96% Cl=10.31% N=4.07%
Storage and Stability
Lyophilized and reconstituted products are stable for 6 months after receipt at -20°C. Reconstitute with sterile buffer. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Important Note
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
References
1. Chiba, K., et al. "Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus." Cell Mol. Immunol. 3:11-19 (2006). 3. Dev, K.K., et al. "Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosis." Pharmacol. Ther. 117:77-93 (2008). 3. Kunzendorf, U., et al. "FTY720—the first compound of a new promising class of immunosuppressive drugs." Nephrol. Dial. Transplant. 19:1677-1681 (2004). 4. Yopp, A.C., et al. "Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants." Clin. Transplant. 20:788-795 (2006).USBio References
No references available